Cargando…

Recovery from hepatitis A after Korean medicine-based treatment: a case report

BACKGROUND: Many studies reported that Korean medicine (KM) is effective for treating liver disease, including hepatitis A. However, KM, specifically with herbal medicine (Chungganplus, CGP) has not been reported yet. We aimed to report a patient with hepatitis A who was treated with KM including CG...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Chan-Ran, Lee, Gayoung, Son, Chang-Gue, Cho, Jung-Hyo, Lee, Nam-Hun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872770/
https://www.ncbi.nlm.nih.gov/pubmed/31768311
http://dx.doi.org/10.1016/j.imr.2019.11.001
_version_ 1783472559616950272
author Park, Chan-Ran
Lee, Gayoung
Son, Chang-Gue
Cho, Jung-Hyo
Lee, Nam-Hun
author_facet Park, Chan-Ran
Lee, Gayoung
Son, Chang-Gue
Cho, Jung-Hyo
Lee, Nam-Hun
author_sort Park, Chan-Ran
collection PubMed
description BACKGROUND: Many studies reported that Korean medicine (KM) is effective for treating liver disease, including hepatitis A. However, KM, specifically with herbal medicine (Chungganplus, CGP) has not been reported yet. We aimed to report a patient with hepatitis A who was treated with KM including CGP, acupuncture, and moxibustion for 12 days. METHODS: A 39-year-old man with hepatitis A who was hospitalized for 12 days after being admitted to our hospital with abdominal pain, diarrhea and vomiting. We prescribed CGP three times a day, with acupuncture performed twice daily and moxibustion at conception vessel (CV)-12 once a day. Follow-up blood tests have been done 4 times during the admission in order to access the effect of the treatment. RESULTS: In 12 days the symptoms had disappeared and the blood test results improved steadily. His AST level have declined from 1,189 IU/L to 44 IU/L, ALT from 2,423 IU/L to 127 IU/L, r-GTP from 1,347 IU/L to 339 IU/L, ALP from 384 IU/L to 205 IU/L, and total bilirubin from 3.6 mg/dL to 0.89 mg/dL. CONLCUSION: This case suggests that KM-based treatment using CGP may be effective for hepatitis A with no adverse effect. Further research and clinical trial on CGP would be needed to make the basis more valid.
format Online
Article
Text
id pubmed-6872770
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-68727702019-11-25 Recovery from hepatitis A after Korean medicine-based treatment: a case report Park, Chan-Ran Lee, Gayoung Son, Chang-Gue Cho, Jung-Hyo Lee, Nam-Hun Integr Med Res Case Report BACKGROUND: Many studies reported that Korean medicine (KM) is effective for treating liver disease, including hepatitis A. However, KM, specifically with herbal medicine (Chungganplus, CGP) has not been reported yet. We aimed to report a patient with hepatitis A who was treated with KM including CGP, acupuncture, and moxibustion for 12 days. METHODS: A 39-year-old man with hepatitis A who was hospitalized for 12 days after being admitted to our hospital with abdominal pain, diarrhea and vomiting. We prescribed CGP three times a day, with acupuncture performed twice daily and moxibustion at conception vessel (CV)-12 once a day. Follow-up blood tests have been done 4 times during the admission in order to access the effect of the treatment. RESULTS: In 12 days the symptoms had disappeared and the blood test results improved steadily. His AST level have declined from 1,189 IU/L to 44 IU/L, ALT from 2,423 IU/L to 127 IU/L, r-GTP from 1,347 IU/L to 339 IU/L, ALP from 384 IU/L to 205 IU/L, and total bilirubin from 3.6 mg/dL to 0.89 mg/dL. CONLCUSION: This case suggests that KM-based treatment using CGP may be effective for hepatitis A with no adverse effect. Further research and clinical trial on CGP would be needed to make the basis more valid. Elsevier 2019-12 2019-11-07 /pmc/articles/PMC6872770/ /pubmed/31768311 http://dx.doi.org/10.1016/j.imr.2019.11.001 Text en © 2019 Korea Institute of Oriental Medicine. Published by Elsevier. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Park, Chan-Ran
Lee, Gayoung
Son, Chang-Gue
Cho, Jung-Hyo
Lee, Nam-Hun
Recovery from hepatitis A after Korean medicine-based treatment: a case report
title Recovery from hepatitis A after Korean medicine-based treatment: a case report
title_full Recovery from hepatitis A after Korean medicine-based treatment: a case report
title_fullStr Recovery from hepatitis A after Korean medicine-based treatment: a case report
title_full_unstemmed Recovery from hepatitis A after Korean medicine-based treatment: a case report
title_short Recovery from hepatitis A after Korean medicine-based treatment: a case report
title_sort recovery from hepatitis a after korean medicine-based treatment: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872770/
https://www.ncbi.nlm.nih.gov/pubmed/31768311
http://dx.doi.org/10.1016/j.imr.2019.11.001
work_keys_str_mv AT parkchanran recoveryfromhepatitisaafterkoreanmedicinebasedtreatmentacasereport
AT leegayoung recoveryfromhepatitisaafterkoreanmedicinebasedtreatmentacasereport
AT sonchanggue recoveryfromhepatitisaafterkoreanmedicinebasedtreatmentacasereport
AT chojunghyo recoveryfromhepatitisaafterkoreanmedicinebasedtreatmentacasereport
AT leenamhun recoveryfromhepatitisaafterkoreanmedicinebasedtreatmentacasereport